Identification
- Generic Name
- 4-PHENOXY-N-(PYRIDIN-2-YLMETHYL)BENZAMIDE
- DrugBank Accession Number
- DB07459
- Background
Not Available
- Type
- Small Molecule
- Groups
- Experimental
- Structure
Structure for 4-PHENOXY-N-(PYRIDIN-2-YLMETHYL)BENZAMIDE (DB07459)
- Weight
- Average: 304.3425
Monoisotopic: 304.121177766 - Chemical Formula
- C19H16N2O2
- Synonyms
- Not Available
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
Avoid life-threatening adverse drug eventsImprove clinical decision support with information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events & improve clinical decision support.- Pharmacodynamics
Not Available
- Mechanism of action
Target Actions Organism UMitogen-activated protein kinase 14 Not Available Humans - Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates.Improve decision support & research outcomes with our structured adverse effects data.- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Categories
- Drug Categories
- Not Available
- Chemical TaxonomyProvided by Classyfire
- Description
- This compound belongs to the class of organic compounds known as diphenylethers. These are aromatic compounds containing two benzene rings linked to each other through an ether group.
- Kingdom
- Organic compounds
- Super Class
- Benzenoids
- Class
- Benzene and substituted derivatives
- Sub Class
- Diphenylethers
- Direct Parent
- Diphenylethers
- Alternative Parents
- Diarylethers / Benzamides / Phenoxy compounds / Phenol ethers / Benzoyl derivatives / Pyridines and derivatives / Heteroaromatic compounds / Secondary carboxylic acid amides / Azacyclic compounds / Organopnictogen compounds show 3 more
- Substituents
- Aromatic heteromonocyclic compound / Azacycle / Benzamide / Benzoic acid or derivatives / Benzoyl / Carboxamide group / Carboxylic acid derivative / Diaryl ether / Diphenylether / Ether show 13 more
- Molecular Framework
- Aromatic heteromonocyclic compounds
- External Descriptors
- Not Available
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- 6J2NXX77VH
- CAS number
- Not Available
- InChI Key
- HVLSCZSVTCNAQX-UHFFFAOYSA-N
- InChI
- InChI=1S/C19H16N2O2/c22-19(21-14-16-6-4-5-13-20-16)15-9-11-18(12-10-15)23-17-7-2-1-3-8-17/h1-13H,14H2,(H,21,22)
- IUPAC Name
- 4-phenoxy-N-[(pyridin-2-yl)methyl]benzamide
- SMILES
- O=C(NCC1=NC=CC=C1)C1=CC=C(OC2=CC=CC=C2)C=C1
References
- General References
- Not Available
- External Links
- PubChem Compound
- 2352168
- PubChem Substance
- 99443930
- ChemSpider
- 1756983
- BindingDB
- 50174097
- ChEBI
- 41135
- ChEMBL
- CHEMBL199237
- ZINC
- ZINC000013284470
- PDBe Ligand
- BI5
- PDB Entries
- 1zyj
Clinical Trials
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
- Not Available
- Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Solid
- Experimental Properties
- Not Available
- Predicted Properties
Property Value Source Water Solubility 0.011 mg/mL ALOGPS logP 3.4 ALOGPS logP 3.14 Chemaxon logS -4.4 ALOGPS pKa (Strongest Acidic) 14.63 Chemaxon pKa (Strongest Basic) 4.14 Chemaxon Physiological Charge 0 Chemaxon Hydrogen Acceptor Count 2 Chemaxon Hydrogen Donor Count 1 Chemaxon Polar Surface Area 51.22 Å2 Chemaxon Rotatable Bond Count 5 Chemaxon Refractivity 88.21 m3·mol-1 Chemaxon Polarizability 32.64 Å3 Chemaxon Number of Rings 3 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter Yes Chemaxon Veber's Rule No Chemaxon MDDR-like Rule No Chemaxon - Predicted ADMET Features
Property Value Probability Human Intestinal Absorption + 0.996 Blood Brain Barrier + 0.9951 Caco-2 permeable + 0.6603 P-glycoprotein substrate Non-substrate 0.5966 P-glycoprotein inhibitor I Non-inhibitor 0.8523 P-glycoprotein inhibitor II Non-inhibitor 0.9074 Renal organic cation transporter Non-inhibitor 0.5374 CYP450 2C9 substrate Non-substrate 0.8477 CYP450 2D6 substrate Non-substrate 0.5639 CYP450 3A4 substrate Non-substrate 0.5494 CYP450 1A2 substrate Inhibitor 0.7745 CYP450 2C9 inhibitor Non-inhibitor 0.671 CYP450 2D6 inhibitor Non-inhibitor 0.875 CYP450 2C19 inhibitor Non-inhibitor 0.6417 CYP450 3A4 inhibitor Non-inhibitor 0.8172 CYP450 inhibitory promiscuity High CYP Inhibitory Promiscuity 0.7184 Ames test Non AMES toxic 0.7198 Carcinogenicity Non-carcinogens 0.9018 Biodegradation Not ready biodegradable 0.9144 Rat acute toxicity 2.2226 LD50, mol/kg Not applicable hERG inhibition (predictor I) Weak inhibitor 0.9498 hERG inhibition (predictor II) Non-inhibitor 0.7496
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
Spectrum Spectrum Type Splash Key Predicted GC-MS Spectrum - GC-MS Predicted GC-MS Not Available Predicted MS/MS Spectrum - 10V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 20V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 40V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 10V, Negative (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 20V, Negative (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 40V, Negative (Annotated) Predicted LC-MS/MS Not Available
Targets
Build, predict & validate machine-learning models
Use our structured and evidence-based datasets to unlock newinsights and accelerate drug research.
Use our structured and evidence-based datasets to unlock new insights and accelerate drug research.
- Kind
- Protein
- Organism
- Humans
- Pharmacological action
- Unknown
- General Function
- Protein serine/threonine kinase activity
- Specific Function
- Serine/threonine kinase which acts as an essential component of the MAP kinase signal transduction pathway. MAPK14 is one of the four p38 MAPKs which play an important role in the cascades of cellu...
- Gene Name
- MAPK14
- Uniprot ID
- Q16539
- Uniprot Name
- Mitogen-activated protein kinase 14
- Molecular Weight
- 41292.885 Da
References
- Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [Article]
Drug created at September 15, 2010 21:21 / Updated at June 12, 2020 16:52